Skip to main content
Henry Koon Jr., MD, Oncology, Lawrenceville, NJ

HenryBKoonJr.MD

Oncology Lawrenceville, NJ

Hematologic Oncology, Melanoma, Sarcoma

Clinical Trial Lead, Melanoma

Dr. Koon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Koon's full profile

Already have an account?

  • Office

    Bristol Myers Squibb
    3401 Princeton Pike
    Lawrenceville, NJ 08648

Summary

  • Dr. Henry Koon is an oncologist in Lawrenceville, NJ. He received his medical degree from University of Mississippi School of Medicine and has been in practice 23 years. He specializes in hematologic oncology and is experienced in sarcomas, melanoma and cutaneous malignancies.

Education & Training

  • University of Mississippi Medical Center
    University of Mississippi Medical CenterResidency, Internal Medicine, 1994 - 1997
  • University of Mississippi School of Medicine
    University of Mississippi School of MedicineClass of 1994

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2007 - 2026

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Leap Therapeutics Presents Data from Phase 1 Study of GITR Agonist
    Leap Therapeutics Presents Data from Phase 1 Study of GITR AgonistNovember 12th, 2016
  • Leap Therapeutics Presents Data from Phase 1 Single Dose Safety Study of Anti-GITR Immunotherapy TRX518 in Patients with Advanced Relapsed or Refractory Solid Tumors at American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
    Leap Therapeutics Presents Data from Phase 1 Single Dose Safety Study of Anti-GITR Immunotherapy TRX518 in Patients with Advanced Relapsed or Refractory Solid Tumors at American Society of Clinical Oncology (ASCO) 2016 Annual MeetingJune 5th, 2016

Professional Memberships